The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria
Name:
s12905-023-02782-6.pdf
Size:
1005.Kb
Format:
PDF
Description:
Final Published Version
Author
Habila, M.A.Obeng-Kusi, M.
Ali, M.J.
Magaji, F.A.
Shambe, I.H.
Daru, P.H.
Jacobs, E.T.
Madhivanan, P.
Sagay, A.S.
Musa, J.
Affiliation
Mel and Enid, Department of Epidemiology and Biostatistics, Zuckerman College of Public Health, University of ArizonaDepartment of Health and Pharmaceutical Outcomes, R. Ken Coit College of Pharmacy, University of Arizona
Mel and Enid, Department of Health Promotion Sciences, Zuckerman College of Public Health, University of Arizona
Issue Date
2023-11-30
Metadata
Show full item recordPublisher
BioMed Central LtdCitation
Habila, M.A., Obeng-Kusi, M., Ali, M.J. et al. The impact of the COVID-19 pandemic on routine HIV care and cervical cancer screening in North-Central Nigeria. BMC Women's Health 23, 640 (2023). https://doi.org/10.1186/s12905-023-02782-6Journal
BMC Women's HealthRights
© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.Collection Information
This item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at repository@u.library.arizona.edu.Abstract
Introduction: Cervical cancer is the fourth most diagnosed cancer among women globally, with much of the burden being carried by women in limited-resource settings often worsened by the high prevalence of HIV. Furthermore, the COVID-19 pandemic disrupted organized screening efforts and HIV management regimens worldwide, and the impact of these disruptions have not been examined in these settings. The purpose of this paper is to describe whether uptake of cervical cancer screening and HIV management changed before, during, and since the COVID-19 pandemic in North-Central Nigeria. Methods: Longitudinal healthcare administration data for women who obtained care between January 2018 and December 2021 were abstracted from the AIDS Prevention Initiative Nigeria (APIN) clinic at Jos University Teaching Hospital. Patient demographics, pap smear outcomes, and HIV management indicators such as viral load and treatment regimen were abstracted and assessed using descriptive and regression analyses. All analyses were conducted comparing two years prior to the COVID-19 pandemic, the four quarters in 2020, and the year following COVID-19 restrictions. Results: We included 2304 women in the study, most of whom were between 44 and 47 years of age, were married, and had completed secondary education. About 85% of women were treated with first line highly active retroviral therapy (HAART). Additionally, 84% of women screened using pap smear had normal results. The average age of women who sought care at APIN was significantly lower in Quarter 3, 2020 (p = 0.015) compared to the other periods examined in this study. Conversely, the average viral load for women who sought care during that period was significantly higher in adjusted models (p < 0.0001). Finally, we determined that the average viral load at each clinic visit was significantly associated with the period in which women sought care. Conclusions: Overall, we found that COVID-19 pandemic mitigation efforts significantly influenced women’s ability to obtain cervical cancer screening and routine HIV management at APIN clinic. This study buttresses the challenges in accessing routine and preventive care during the COVID-19 pandemic, especially in low-resource settings. Further research is needed to determine how these disruptions to care may influence long-term health in this and similar at-risk populations. © 2023, The Author(s).Note
Open access journalISSN
1472-6874PubMed ID
38037005Version
Final Published Versionae974a485f413a2113503eed53cd6c53
10.1186/s12905-023-02782-6
Scopus Count
Collections
Except where otherwise noted, this item's license is described as © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License.
Related articles
- Community cervical cancer screening and precancer risk in women living with HIV in Jos Nigeria.
- Authors: Magaji FA, Mashor MI, Anzaku SA, Hinjari AR, Cosmas NT, Kwaghe BV, Ali JM, Christian EN, Sagay AS, Chandler A, Khan I, Murphy RL, Hou L, Musa J
- Issue date: 2024 Jan 16
- Utilization of opportunistic cervical cancer screening in Nigeria.
- Authors: Habila MA, Sagay E, Obeng-Kusi M, Ali MJ, Magaji FA, Shambe IH, Daru PH, Jacobs ET, Madhivanan P, Sagay AS, Musa J
- Issue date: 2024 Jan
- Self-reported history of Pap-smear in HIV-positive women in Northern Italy: a cross-sectional study.
- Authors: Dal Maso L, Franceschi S, Lise M, De' Bianchi PS, Polesel J, Ghinelli F, Falcini F, Finarelli AC, Screening of HIV-positive women in Emilia-Romagna (SHER) Study
- Issue date: 2010 Jun 21
- An unmet cancer screening need of HIV-positive women in southeastern Nigeria.
- Authors: Dim CC, Dim NR, Ezegwui HU, Ikeme AC
- Issue date: 2009
- The need to incorporate routine cervical cancer counselling and screening in the management of HIV positive women in Nigeria.
- Authors: Rabiu KA, Akinbami AA, Adewunmi AA, Akinola OI, Wright KO
- Issue date: 2011